REFERENCES
- Velez G, Bassuk AG, Colgan D, Tsang SH, Mahajan VB Therapeutic drug repositioning using personalized proteomics of liquid biopsies. LID - 10.1172/jci.insight.97818 [doi] LID - 97818 [pii]. (2379-3708 (Electronic)).
- Mahajan VB, Skeie JM, Bassuk AG, et al. Calpain-5 mutations cause autoimmune uveitis, retinal neovascularization, and photoreceptor degeneration. PLoS Genet. 2012;8(10):e1003001. doi:10.1371/journal.pgen.1003001.
- Velez G, Bassuk AG, Schaefer KA, et al. A novel de novo CAPN5 mutation in a patient with inflammatory vitreoretinopathy, hearing loss, and developmental delay. Cold Spring Harb Mol Case Stud. 2018. doi:10.1101/mcs.a002519.
- Wert KJ, Bassuk AG, Wu WH, et al. CAPN5 mutation in hereditary uveitis: the R243L mutation increases calpain catalytic activity and triggers intraocular inflammation in a mouse model. Hum Mol Genet. 2015;24(16):4584–4598. doi:10.1093/hmg/ddv189.
- Wang Y, Li H, Zang S, et al. Photoreceptor cell-derived CAPN5 regulates retinal pigment epithelium cell proliferation through direct regulation of SLIT2 cleavage. Invest Ophthalmol Vis Sci. 2018;59(5):1810–1821. doi:10.1167/iovs.17-22689.